BLM and cancer: However, some studies have reported an increased risk of cancer in heterozygous carriers of autosomal recessive PID associated variants, heterozygous BLM (Bloom syndrome, AR) mutations, and heterozygous ATM (Ataxia-telangiectasia, AR) mutations34, 35.